Ubenimex Suppresses the Ability of Migration and Invasion in Gastric Cancer Cells by Alleviating the Activity of the CD13/NAB1/MAPK Pathway

References

• Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40(3):250–260. doi:10.1111/apt.1281424912650
   PubMed Web of Science ®Google Scholar
• Bianca B, Meyer TF. The human gastric pathogen helicobacter pylori and its association with gastric cancer and ulcer disease. Ulcers. 2011;2011:1–23. doi:10.1155/2011/340157
   Google Scholar
• Khushalani NI. Cancer of the esophagus and stomach. Practitioner. 2008;83(6):712–722. doi:10.1016/S0025-6196(11)60900-2
   Google Scholar
• Ruan T, Liu W, Tao K, Wu CA. Review of research progress in multidrug-resistance mechanisms in gastric cancer. Onco Targets Ther. 2020;13:1797–1807. doi:10.2147/OTT.S23933632184615
   PubMed Web of Science ®Google Scholar
• Jun SY, Park JK. Metachronous ovarian metastases following resection of the primary gastric cancer. J Gastric Cancer. 2011;11(1):31–37. doi:10.5230/jgc.2011.11.1.3122076199
   PubMedGoogle Scholar
• Guzman-Rojas L, Rangel R, Salameh A, et al. Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment. Proc Natl Acad Sci U S A. 2012;109(5):1637–1642. doi:10.1073/pnas.112079010922307623
   PubMed Web of Science ®Google Scholar
• Highley MS, Parnis FX, Trotter GA, et al. Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma. Br J Surg. 1994;81(12):1763–1765. doi:10.1002/bjs.18008112187530150
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Sugiyama K, Ichihara K. Effect of ubenimex on the immune system of patients with hematological malignancies. Biomed Pharmacother. 1991;45(2–3):105–112. doi:10.1016/0753-3322(91)90129-h1912365
   PubMed Web of Science ®Google Scholar
• Swirnoff AH, Apel ED, Svaren J, et al. Nab1, a corepressor of NGFI-A (Egr-1), contains an active transcriptional repression domain. Mol Cell Biol. 1998;18(1):512–524. doi:10.1128/mcb.18.1.5129418898
   PubMed Web of Science ®Google Scholar
• LaVallee J, Grant T, D’Angelo-Early S, et al. Refining the nuclear localization signal within the Egr transcriptional coregulator NAB2. FEBS Lett. 2019;593(1):107–118. doi:10.1002/1873-3468.1328830411343
   PubMed Web of Science ®Google Scholar
• Zhao L, Yuan Y, Li P, et al. miR-221-3p inhibits schwann cell myelination. Neuroscience. 2018;379:239–245. doi:10.1016/j.neuroscience.2018.03.01929577996
   PubMed Web of Science ®Google Scholar
• Tikiyani V, Li L, Sharma P, Liu H, Hu Z, Babu K. Wnt secretion is regulated by the tetraspan protein HIC-1 through its interaction with neurabin/NAB-1. Cell Rep. 2018;25(7):1856–1871.e6. doi:10.1016/j.celrep.2018.10.05330428353
   PubMed Web of Science ®Google Scholar
• Qiu FH, Devchand PR, Wada K, Serhan CN. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils. FASEB J. 2001;15(14):2736–2738. doi:10.1096/fj.01-0576fje11687510
   PubMed Web of Science ®Google Scholar
• Xiang Z, Li J, Song S, et al. A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis. J Exp Clin Cancer Res. 2019;38(1):314. doi:10.1186/s13046-019-1318-531315643
   PubMed Web of Science ®Google Scholar
• Liu H, Zhao YR, Chen B, Ge Z, Huang JS. High expression of SMARCE1 predicts poor prognosis and promotes cell growth and metastasis in gastric cancer. Cancer Manag Res. 2019;11:3493–3509. doi:10.2147/CMAR.S19513731118775
   PubMed Web of Science ®Google Scholar
• Wong D, Kandagatla P, Korz W, Chinni SR. Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis. BMC Urol. 2014;14(1):12. doi:10.1186/1471-2490-14-1224472670
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Suzuki M, Kanayama N, Terao T. Genetic down-regulation of phosphoinositide 3-kinase by bikunin correlates with suppression of invasion and metastasis in human ovarian cancer HRA cells. J Biol Chem. 2004;279(8):6371–6379. doi:10.1074/jbc.M30574920014597629
   PubMed Web of Science ®Google Scholar
• Kosla J, Dvorakova M, Dvorak M, Cermak V. Effective myofibroblast dedifferentiation by concomitant inhibition of TGF-β signaling and perturbation of MAPK signaling. Eur J Cell Biol. 2013;92(12):363–373. doi:10.1016/j.ejcb.2013.10.01324315689
   PubMed Web of Science ®Google Scholar
• Sakuraya M, Tamura J, Itoh K, Kubota K, Naruse T. Aminopeptidase inhibitor ubenimex inhibits the growth of leukaemic cell lines and myeloma cells through its cytotoxicity. J Int Med Res. 2000;28(5):214–221. doi:10.1177/14732300000280050311092231
   PubMed Web of Science ®Google Scholar
• Urabe A, Mutoh Y, Mizoguchi H, Takaku F, Ogawa N. Ubenimex in the treatment of acute nonlymphocytic leukemia in adults. Ann Hematol. 1993;67(2):63–66. doi:10.1007/BF017881288347731
   PubMed Web of Science ®Google Scholar
• Riemann D, Kehlen A, Langner J. CD13–not just a marker in leukemia typing. Immunol Today. 1999;20(2):83–88. doi:10.1016/s0167-5699(98)01398-x10098327
   PubMedGoogle Scholar
• Haraguchi N, Ishii H, Mimori K, et al. CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest. 2010;120(9):3326–3339. doi:10.1172/JCI4255020697159
   PubMed Web of Science ®Google Scholar
• Saiki I, Fujii H, Yoneda J, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer. 1993;54(1):137–143. doi:10.1002/ijc.29105401228097496
   PubMed Web of Science ®Google Scholar
• Pang L, Zhang N, Xia Y, Wang D, Wang G, Meng X. Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer. Oncotarget. 2016;7(47):77854–77864. doi:10.18632/oncotarget.1283527788483
   PubMedGoogle Scholar
• Russo MW, Sevetson BR, Milbrandt J. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc Natl Acad Sci U S A. 1995;92(15):6873–6877. doi:10.1073/pnas.92.15.68737624335
   PubMed Web of Science ®Google Scholar
• Sagrillo CA, Selmanoff M. Effects of prolactin on expression of the mRNAs encoding the immediate early genes zif/268 (NGF1-A), nur/77 (NGF1-B), c-fos and c-jun in the hypothalamus. Brain Res Mol Brain Res. 1998;61(1–2):62–68. doi:10.1016/s0169-328x(98)00198-39795138
   PubMedGoogle Scholar
• Morinobu S, Strausbaugh H, Terwilliger R, Duman RS. Regulation of c-Fos and NGF1-A by antidepressant treatments. Synapse. 1997;25(4):313–320. doi:10.1002/(SICI)1098-2396(199704)25:4<313::AID-SYN1>3.0.CO;2-D9097389
   PubMed Web of Science ®Google Scholar
• Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 2005;6(5):322–327. doi:10.1016/S1470-2045(05)70168-615863380
   PubMed Web of Science ®Google Scholar
• Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev. 2012;92(2):689–737. doi:10.1152/physrev.00028.201122535895
   PubMed Web of Science ®Google Scholar
• Hsieh YY, Shen CH, Huang WS, et al. Resistin-induced stromal cell-derived factor-1 expression through toll-like receptor 4 and activation of p38 MAPK/NFκB signaling pathway in gastric cancer cells. J Biomed Sci. 2014;21(1):59. doi:10.1186/1423-0127-21-5924929539
   PubMed Web of Science ®Google Scholar
• Deak M, Clifton AD, Lucocq LM, Alessi DR. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 1998;17(15):4426–4441. doi:10.1093/emboj/17.15.44269687510
   PubMed Web of Science ®Google Scholar
• Wei L, Li Y, Suo Z. TSPAN8 promotes gastric cancer growth and metastasis via ERK MAPK pathway. Int J Clin Exp Med. 2015;8(6):8599–8607.26309511
   PubMed Web of Science ®Google Scholar
• Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9(9):726–735. doi:10.1096/fasebj.9.9.76013377601337
   PubMed Web of Science ®Google Scholar
• Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004;68(2):320–344. doi:10.1128/MMBR.68.2.320-344.200415187187
   PubMed Web of Science ®Google Scholar
• Liu LP, Sheng XP, Shuai TK, Zhao YX, Li B, Li YM. Helicobacter pylori promotes invasion and metastasis of gastric cancer by enhancing heparanase expression. World J Gastroenterol. 2018;24(40):4565–4577. doi:10.3748/wjg.v24.i40.456530386106
   PubMed Web of Science ®Google Scholar
• Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and independent mechanisms. Science. 1999;286(5443):1358–1362. doi:10.1126/science.286.5443.135810558990
   PubMed Web of Science ®Google Scholar
• Xing J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science. 1996;273(5277):959–963. doi:10.1126/science.273.5277.9598688081
   PubMed Web of Science ®Google Scholar
• Carracedo A, Ma L, Teruya-Feldstein J, et al. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest. 2008;118(9):3065–3074. doi:10.1172/JCI3473918725988
   PubMed Web of Science ®Google Scholar
• Song YX, Yue ZY, Wang ZN, et al. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer. 2011;10(1):1. doi:10.1186/1476-4598-10-21205300
   PubMed Web of Science ®Google Scholar